Bank Of America Corp Biomarin Pharmaceutical Inc Put Options Transaction History

Bank Of America Corp

  • $1.12 Trillion
  • Q2 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$74.43 - $92.22 $10.4 Million - $12.9 Million
140,000 New
140,000 $11.5 Million
Q2 2022

Aug 12, 2022
BUY
$71.48 - $86.85 $1.98 Million - $2.41 Million
27,700 Added 3462.5%
28,500 $2.36 Million
Q4 2021

Feb 08, 2022
SELL
$71.72 - $91.47 $3.01 Million - $3.84 Million
-42,000 Reduced 98.13%
800 $71,000
Q2 2021

Sep 13, 2021
BUY
$75.51 - $84.79 $3.23 Million - $3.63 Million
42,800 New
42,800 $3.57 Million

Others Institutions Holding BMRN

# of Institutions
631
Shares Held
185M
Call Options Held
1.63M
Put Options Held
1.2M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $15.8B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email